Завершено
Фаза III
Россия
ART-123; Placebo · Asahi Kasei Pharma America Corporation
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Safety and Efficacy of ART-123 in Subjects With Severe Sepsis and Coagulopathy.